These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7506197)

  • 21. Are there any differences among non-steroidal anti-inflammatory drugs? Focus on nimesulide.
    Dallegri F; Ottonello L
    Clin Drug Investig; 2007 Dec; 27 Suppl 1():15-22. PubMed ID: 23392786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unique metabolite of nimesulide.
    Sarkar P; McIntosh JM; Leavitt R; Gouthro H
    J Anal Toxicol; 1997; 21(3):197-202. PubMed ID: 9171202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nimesulide spectrophotometric determination in the visible region].
    Perju AC; Mândrescu M; Spac AF; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):535-9. PubMed ID: 17983199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nimesulide: 25 years later].
    Mattia C; Ciarcia S; Muhindo A; Coluzzi F
    Minerva Med; 2010 Aug; 101(4):285-93. PubMed ID: 21030939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium N-(methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)sulfamate: a water-soluble nimesulide prodrug for parenteral use.
    Rapposelli S; Digiacomo M; Franchi S; Moretti S; Pinza M; Sacerdote P; Balsamo A
    Mol Pharm; 2010 Oct; 7(5):1871-6. PubMed ID: 23282004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of nimesulide and paracetamol in the treatment of fever due to inflammatory diseases of the upper respiratory tract in children.
    Polidori G; Titti G; Pieragostini P; Comito A; Scaricabarozzi I
    Drugs; 1993; 46 Suppl 1():231-3. PubMed ID: 7506180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of suspension composition on the pharmacokinetics of nimesulide in rats.
    Carrasco-Portugal Mdel C; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2008; 51():58-9. PubMed ID: 19544678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states.
    Taylor IW; Taylor T; James I; Doyle G; Dorf G; Darragh A; Chasseaud LF
    Eur J Clin Pharmacol; 1991; 40(1):101-6. PubMed ID: 2060536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diclofenac vs nimesulide in arthrosis. Plasma levels and clinical efficacy].
    Estevez F; Amaro G; Giusti M; Lasalvia L; Havranek H
    Medicina (B Aires); 1993; 53(4):307-14. PubMed ID: 8201912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency.
    Tomlinson B; Thomas NG; Lan IW; Barbanoj M; Antonijoan RM; Drazna E; Ramis J; Obach R; Peraire C
    Clin Pharmacokinet; 2006; 45(10):1003-11. PubMed ID: 16984213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and general tolerability of repeated doses of nimesulide in normal subjects.
    Warrington SJ; Ravic M; Dawnay A
    Drugs; 1993; 46 Suppl 1():263-9. PubMed ID: 7506187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus.
    Rainsford KD;
    Curr Med Res Opin; 2006 Jun; 22(6):1161-70. PubMed ID: 16846549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical assessment of the potential for pharmacological interaction between nimesulide and digoxin in patients with heart failure.
    Baggio E; Maraffi F; Montalto C; Nava ML; Torti L; Casciarri I
    Drugs; 1993; 46 Suppl 1():91-4. PubMed ID: 7506200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimesulide binding to components within blood.
    Bree F; Nguyen P; Urien S; Albengres E; Macciocchi A; Tillement JP
    Drugs; 1993; 46 Suppl 1():83-90. PubMed ID: 7506199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
    de Zeeuw D; Remuzzi G; Kirch W
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S37-42. PubMed ID: 9331004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.
    Litalien C; Jacqz-Aigrain E
    Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states.
    Ward A; Brogden RN
    Drugs; 1988 Dec; 36(6):732-53. PubMed ID: 3065059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADMINISTRATION OF H2 BLOCKERS IN NSAID INDUCED GASTROPATHY IN RATS: effect on histopathological changes in gastric, hepatic and renal tissues.
    Manocha S; Lal D; Venkataraman S
    Arq Gastroenterol; 2016; 53(1):36-43. PubMed ID: 27281503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hollow fiber liquid-phase microextraction for the determination of nimesulide in human plasma and its application to a pharmacokinetic study.
    Yang WW; Zhang HF; Jia YR; Zhao T; Zhao YL; Tong LJ; Sun LX
    Pharmazie; 2011 Aug; 66(8):564-9. PubMed ID: 21901977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.